Antidepressant use, age, health linked to abnormal binocular vision

Article

According to research from the University of Waterloo in Canada, abnormal binocular vision dramatically increases with age, but is correlated with a patient’s general health and antidepressant use.

Waterloo, Canada-According to research from the University of Waterloo in Canada, abnormal binocular vision dramatically increases with age, but is correlated with a patient’s general health and antidepressant use. 

The study looked at records from 500 patients, ages 60 and over, who received treatment at the university’s on-campus clinic. Data included age, general and ocular history and symptoms, antidepressant use, smoking habits, refraction, visual acuity, binocular vision and eye movement status for the most recent full oculo-visual assessment, and an assessment from 10 years prior.

The study found that about 27 percent of adults in their 60s have a binocular vision or eye movement disorder, and that number rises to 38 percent for those over age 80. Age and use of antidepressants most commonly predicted binocular vision or eye movement disorders. In addition, about 20 percent of the general population has a binocular vision disorder.

According to the university, “Conditions such as diabetes and thyroid disease are known to cause such problems, but this is the first study to link binocular vision disorders with overall general health. Similarly, other writers have discussed a possible association between certain antidepressant drugs and specific binocular vision disorders, but this is the first study to actually demonstrate a link between antidepressant use and binocular vision and eye movement disorders.

"An association does not establish that one causes the other, but rather that they co-exist," says Susan Leat, BSc, PhD, FAAO, PCOptom, who led the study. "It is possible that the effects of poor vision mean that people are more likely to take anti-depressants or make less healthy lifestyle choices."

Next: Glaucoma drug may reverse obesity-related vision loss

Tracrolimus drops associated with improvement of refractory allergic ocular disease

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Presenters from the Collaborative Care Symposium 2025 give their key takeaways from their presentations.
Erin Tomiyama, OD, PhD, FAAO, offers actionable advice for myopia management and perspective for practitioners ready to refine their approach.
Extended lotilaner 0.25% therapy shows meibomian gland benefits
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Carolyn Majcher, OD, FAAO, details a Collaborative Care Symposium 2025 presentation given with Prethy Rao, MD.
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Lori Wright, JD, sat down to talk about a presentation at Collaborative Care Symposium about the risk under federal statutes and how to minimize that risk as an optometrist or an ophthalmic practice.
Rachelle Lin, OD, MS, FAAO, on collaborating more effectively on neovascular retinal cases
Mark Bullimore, MCOptom, PhD, details the importance of preparing optometric students for myopic patient care in a Collaborative Care Symposium (CCS) 2025 presentation.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
© 2025 MJH Life Sciences

All rights reserved.